© 2018 Sach & Associates

Please reload

Recent Posts

Five actions an Amazon seller should take when a product listing has been removed because of an unjustified design right complaint

September 19, 2018

1/1
Please reload

Featured Posts

Sach & Associates successful in revoking EpiPen patent in Europe

June 3, 2018

Sach & Associates has been successful in revoking another EpiPen patent in European Patent Office (EPO) opposition proceedings.  The opposition was filed against Pfizer's European EpiPen patent.  The hearing took place in April 2018 and the written decision to revoke the patent issued in May 2018.  This is the second successful opposition by ALK-Abello (represented by Sach & Associates) to Meridian Medical Technologies' EpiPen patents in Europe.  The European patent revocation leaves Meridian Medical Technologies without patent protection for EpiPen in Europe. 

 

 

The European Patent Office file for the oppositions can be found here:

https://register.epo.org/application?number=EP05783727

and here:

https://register.epo.org/application?number=EP10194414

 

A press report on the opposition can be found here:

https://www.lifesciencesipreview.com/news/epipen-patent-revoked-in-europe-2829

 

 

 

Share on Facebook
Share on Twitter
Please reload

Follow Us
Please reload

Search By Tags